Read article here
No, I did not long nor follow this stock at all. And it is fine that I did not participate and lose out this great , great opportunity costs as some followers were asking me about.
From the 1H chart, it looks like some pull back is likely before it continues its climb. There are 2 gaps that potentially can be filled up as well.
I tend to stay away from such speculative stocks as capital management is key and the more you want to increase your probability of success, the more careful you are with your stock selection.
Who knows, down the road, this Eastman Kodak could be the phoenix from the rising ash and turn into a multi-bagger. Till then, it is out of my radar.
All the best to those who trade and made the 500% profits !!!
No, I did not long nor follow this stock at all. And it is fine that I did not participate and lose out this great , great opportunity costs as some followers were asking me about.
From the 1H chart, it looks like some pull back is likely before it continues its climb. There are 2 gaps that potentially can be filled up as well.
I tend to stay away from such speculative stocks as capital management is key and the more you want to increase your probability of success, the more careful you are with your stock selection.
Who knows, down the road, this Eastman Kodak could be the phoenix from the rising ash and turn into a multi-bagger. Till then, it is out of my radar.
All the best to those who trade and made the 500% profits !!!
ความคิดเห็น:
moving to close the gap 2
ความคิดเห็น:
gap 2 is closed , now we left with one more gap to go.
www.marketwatch...held-2020-08-10?mod=home-p...
www.marketwatch...held-2020-08-10?mod=home-p...
ความคิดเห็น:
sadly, the euphoria party is over ......
ความคิดเห็น:
gap 1 50% partially closed......
ความคิดเห็น:
Another stock with a sensational story but failed to last.....
ความคิดเห็น:
Eastman Kodak — The camera company’s stock jumped 59.9% after The Wall Street Journal reported that a government watchdog found no wrongdoing in Kodak getting a government loan to produce pharmaceutical ingredients. The loan, worth more than $700 million, sent shares soaring when it was first announced in July, but Kodak’s stock deflated when a government agency put the deal on hold. (CNBC)